9960 logo

Kindstar Globalgene Technology, Inc. Stock Price

SEHK:9960 Community·HK$1.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

9960 Share Price Performance

HK$1.15
0.02 (1.77%)
HK$1.15
0.02 (1.77%)
Price HK$1.15

9960 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

1 Risk
1 Reward

Kindstar Globalgene Technology, Inc. Key Details

CN¥933.6m

Revenue

CN¥522.7m

Cost of Revenue

CN¥410.9m

Gross Profit

CN¥469.6m

Other Expenses

-CN¥58.7m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-0.059
44.01%
-6.29%
13.7%
View Full Analysis

About 9960

Founded
2003
Employees
3100
CEO
Shiang Huang
WebsiteView website
www.kindstar.com.cn

Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People’s Republic of China. The company offers its esoteric testing services for hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology diseases. It also provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules, and evaluation for curative effect of specialized diseases. The company’s lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research testing laboratories. The company was founded in 2003 and is headquartered in Wuhan, the People’s Republic of China.

Recent 9960 News & Updates

Recent updates

No updates